US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

2.0100
0.00000.00%

Close Nov 21 16:00 ET

2.0100
0.00000.00%

Post 20:05 ET

3.84MMarket Cap-176P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avenue Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Avenue Therapeutics Earnings Reports

Avenue Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 15 05:24

Avenue Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 10 04:20

Avenue Therapeutics | 8-K: Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Aug 10 04:18

Avenue Therapeutics | 10-Q: Q1 2024 Earnings Report

May 16 04:26

Analyst Rating

Updated: Nov 16, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall